Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease

Life Sciences

Volumn 118, Issue 2, 2014, Pages 200-205

  Matsumoto, Takayuki ^a   Watanabe, Shun ^a   Kawamura, Ryusuke ^a   Taguchi, Kumiko ^a   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Carotid artery; EGCG; ET 1; Type 2 diabetes; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; EPIGALLOCATECHIN GALLATE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; CATECHIN; ENDOTHELIN RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; CHRONIC DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; LONG EVANS TOKUSHIMA OTSUKA RAT; LONG TERM CARE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PROTEIN EXPRESSION; RAT; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; CAROTID ARTERY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; CAROTID ARTERIES; CATECHIN; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; IN VITRO TECHNIQUES; MALE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; PHENYLEPHRINE; RATS, INBRED OLETF; RECEPTORS, ENDOTHELIN; SUPEROXIDE DISMUTASE; VASOCONSTRICTION; VASODILATION;

EID: 84942595630     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.11.016     Document Type: Article

References (41)

1. Babu, P.V., Liu, D., Green tea catechins and cardiovascular health: an update. Curr Med Chem 15 (2008), 1840–1850.
2. Babu, P.V., Si, H., Liu, D., Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism. Mol Nutr Food Res 56 (2012), 1424–1432.
3. Cai, H., Griendling, K.K., Harrison, D.G., The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003), 471–478.
4. Ergul, A., Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res 63 (2011), 477–482.
5. Ergul, A., Portik-Dobos, V., Giulumian, A.D., Molero, M.M., Fuchs, L.C., Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am J Physiol Heart Circ Physiol 285 (2003), H2225–H2232.
6. Forbes, J.M., Cooper, M.E., Mechanisms of diabetic complications. Physiol Rev 93 (2013), 137–188.
7. Ihm, S.H., Lee, J.O., Kim, S.J., Seung, K.B., Schini-Kerth, V.B., Chang, K., et al. Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206 (2009), 47–53.
8. Ihm, S.H., Jang, S.W., Kim, O.R., Chang, K., Oak, M.H., Lee, J.O., et al. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis 224 (2012), 377–383.
9. Kagota, S., Yamaguchi, Y., Nakamura, K., Kunitomo, M., Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of noninsulin-dependent diabetes mellitus. Gen Pharmacol 34 (2000), 201–209.
10. Kamata, K., Kobayashi, T., Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol 119 (1996), 583–589.
11. Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., Natori, T., Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992), 1422–1428.
12. Kim, I.J., Kim, Y.K., Son, S.M., Hong, K.W., Kim, C.D., Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia. Diabetes Res Clin Pract 60 (2003), 11–18.
13. A receptors and ERK. Br J Pharmacol 155 (2008), 974–983.
14. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296 (2006), 1255–1265.
15. Martínez-Revelles, S., Caracuel, L., Márquez-Martín, A., Dantas, A., Oliver, E., D'Ocon, P., et al. Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischemia-reperfusion. Br J Pharmacol 165 (2012), 937–950.
16. Matsui, T., Nishino, Y., Takeuchi, M., Yamagishi, S., Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis. Pharmacol Res 63 (2011), 383–388.
17. Matsumoto, T., Kobayashi, T., Kamata, K., Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. J Smooth Muscle Res 44 (2008), 41–55.
18. Matsumoto, T., Ishida, K., Nakayama, N., Kobayashi, T., Kamata, K., Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. Am J Physiol Heart Circ Physiol 296 (2009), H1388–H1397.
19. Matsumoto, T., Nakayama, N., Ishida, K., Kobayashi, T., Kamata, K., Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329 (2009), 324–334.
20. Matsumoto, T., Watanabe, S., Kawamura, R., Taguchi, K., Kobayashi, T., Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygense/thromboxane receptor axis. Pflugers Arch, 2014 [in press].
21. Munir, K.M., Chandrasekaran, S., Gao, F., Quon, M.J., Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: implications for diabetes and its vascular complications. Am J Physiol Endocrinol Metab 305 (2013), E679–E686.
22. Ohkita, M., Tawa, M., Kitada, K., Matsumura, Y., Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci 119 (2012), 302–313.
23. Peng, N., Liu, J.T., Guo, F., Li, R., Epigallocatechin-3-gallate inhibits interleukin-6-and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells. Life Sci 86 (2010), 410–415.
24. Perassolo, M.S., Almeida, J.C., Steemburgo, T., Dall'Alba, V., de Mello, V.D., Zelmanovitz, T., et al. Endothelial dysfunction and serum fatty acid composition in patients with type 2 diabetes mellitus. Metabolism 57 (2008), 1167–1172.
25. Pernow, J., Shemyakin, A., Bohn, F., New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci 91 (2012), 507–516.
26. Porter, K.E., Riches, K., The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?. Clin Sci 125 (2013), 167–182.
27. Potenza, M.A., Marasciulo, F.L., Tarquinio, M., Tiravanti, E., Colantuono, G., Federici, A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292 (2007), E1378–E1387.
28. Potenza, M.A., Gagliardi, S., Nacci, C., Carratu’ MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16 (2009), 94–112.
29. Rask-Madsen, C., King, G.L., Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 3 (2007), 46–56.
30. Reiter, C.E., Kim, J.A., Quon, M.J., Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology 151 (2010), 103–114.
31. Roghani, M., Baluchnejadmojarad, T., Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul Pharmacol 51 (2009), 84–89.
32. Sabu, M.C., Smitha, K., Kuttan, R., Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 83 (2002), 109–116.
33. Sokup, A., Goralczyk, B., Goralczyk, K., Rosc, D., Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes. Acta Obstet Gynecol Scand 91 (2012), 182–188.
34. Tirapelli, C.R., Casolari, D.A., Yogi, A., Montezano, A.C., Tostes, R.C., Legros, E., et al. Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K + channels in ETB-induced relaxation. Br J Pharmacol 146 (2005), 903–912.
35. van Dam, R.M., Naidoo, N., Landberg, R., Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 24 (2013), 25–33.
36. Wang, C.J., Liu, J.T., Guo, F., (-)-Epigallocatechin gallate inhibits endothelin-1-induced C-reactive protein production in vascular smooth muscle cells. Basic Clin Pharmacol Toxicol 107 (2010), 669–675.
37. Wang, M.H., Chang, W.J., Soung, H.S., Chang, K.C., (-)-Epigallocatechin-3-gallate decreases the impairment in learning and memory in spontaneous hypertension rats. Behav Pharmacol 23 (2012), 771–780.
38. Wolfram, S., Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26 (2007), 373S–388S.
39. Wu, C.C., Bohr, D.F., Role of endothelium in the response to endothelin in hypertension. Hypertension 16 (1990), 677–681.
40. Yang, J., Han, Y., Sun, H., Chen, C., He, D., Guo, J., et al. (-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings. J Agric Food Chem 59 (2011), 11483–11490.
41. Yang, J., Han, Y., Chen, C., Sun, H., He, D., Guo, J., et al. EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-kB signaling in human umbilical vein endothelial cells. Life Sci 92 (2013), 589–597.